<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Otolaryngol Head Neck Surg</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Otolaryngol Head Neck Surg</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Otolaryngology-- Head &amp; Neck Surgery</journal-title></journal-title-group><issn pub-type="ppub">2168-6181</issn><issn pub-type="epub">2168-619X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10288380</article-id><article-id pub-id-type="pmcid-ver">PMC10288380.1</article-id><article-id pub-id-type="pmcaid">10288380</article-id><article-id pub-id-type="pmcaiid">10288380</article-id><article-id pub-id-type="pmid">37347472</article-id><article-id pub-id-type="doi">10.1001/jamaoto.2023.1342</article-id><article-id pub-id-type="publisher-id">ooi230031</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group><subj-group subj-group-type="allowCommenting"><subject>Comments</subject></subj-group></article-categories><title-group><article-title>Risk of Cardiovascular Events Among Patients With Head and Neck Cancer</article-title><alt-title alt-title-type="headline">Risk of Cardiovascular Events Among Patients With Head and Neck Cancer</alt-title><alt-title alt-title-type="running-head">Risk of Cardiovascular Events Among Patients With Head and Neck Cancer</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Sun</surname><given-names initials="L">Lova</given-names></name><degrees>MD</degrees><degrees>MSCE</degrees><xref rid="ooi230031aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brody</surname><given-names initials="R">Robert</given-names></name><degrees>MD</degrees><degrees>MSCE</degrees><xref rid="ooi230031aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ooi230031aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Candelieri</surname><given-names initials="D">Danielle</given-names></name><degrees>MPH</degrees><xref rid="ooi230031aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lynch</surname><given-names initials="JA">Julie A.</given-names></name><degrees>PhD</degrees><degrees>MBA</degrees><xref rid="ooi230031aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cohen</surname><given-names initials="RB">Roger B.</given-names></name><degrees>MD</degrees><xref rid="ooi230031aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Y">Yimei</given-names></name><degrees>PhD</degrees><xref rid="ooi230031aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Getz</surname><given-names initials="KD">Kelly D.</given-names></name><degrees>PhD</degrees><degrees>MPH</degrees><xref rid="ooi230031aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ky</surname><given-names initials="B">Bonnie</given-names></name><degrees>MD</degrees><degrees>MSCE</degrees><xref rid="ooi230031aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib></contrib-group><aff id="ooi230031aff1"><label>1</label>Division of Hematology Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia</aff><aff id="ooi230031aff2"><label>2</label>Division of Otorhinolaryngology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia</aff><aff id="ooi230031aff3"><label>3</label>Corporal Michael Crescenz VA Medical Center, Philadelphia, Pennsylvania</aff><aff id="ooi230031aff4"><label>4</label>VA Salt Lake City Health Care System, University of Utah, Salt Lake City</aff><aff id="ooi230031aff5"><label>5</label>Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia</aff><aff id="ooi230031aff6"><label>6</label>Division of Cardiology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> April 27, 2023.</p><p content-type="published-online"><bold>Published Online:</bold> June 22, 2023. doi:<uri content-type="doi">10.1001/jamaoto.2023.1342</uri></p><corresp id="ooi230031cor1"><bold>Corresponding Authors:</bold> Lova Sun, MD, MSCE, Division of Hematology and Oncology, Department of Medicine (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lova.sun@pennmedicine.upenn.edu">lova.sun@pennmedicine.upenn.edu</email>) and Bonnie Ky, MD, MSCE, Division of Cardiology, Department of Medicine (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bonnie.ky@uphs.upenn.edu">bonnie.ky@uphs.upenn.edu</email>), Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA 19104.</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Sun had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Sun, Brody, Ky.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> All authors.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Sun, Brody, Ky.</p><p><italic toggle="yes">Critical revision of the manuscript for important intellectual content:</italic> All authors.</p><p><italic toggle="yes">Statistical analysis:</italic> Sun, Brody, Candelieri-Surette, Lynch, Li, Getz.</p><p><italic toggle="yes">Obtained funding:</italic> Sun.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Brody, Candelieri-Surette, Lynch, Ky.</p><p><italic toggle="yes">Supervision:</italic> Brody, Lynch, Ky.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Sun reported research support from Blueprint, Seagen, IO Biotech, and Erasca as well as personal fees from Sanofi Genzyme, Regeneron, Seagen, and Bayer outside the submitted work. Dr Lynch reported grants from Alnylam, Astellas, AstraZeneca, Biodesix, Celgene, Cerner Enviza, GSK, Janssen, Kantar Health, Myriad Genetic Laboratories, Novartis International AG, and Parexel International Corporation outside the submitted work. Dr Ky reported grants and consulting fees from Pfizer, honorarium from UptoDate, consulting fees from Roche and BMS, grants from the National Institutes of Health and the American Heart Association, and being an editor for the American College of Cardiology outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This study was supported by a pilot faculty grant, from the Department of Otorhinolaryngology at the Perelman School of Medicine at the University of Pennsylvania (Drs Sun and Brody)</p><p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication..</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-OOI230031-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2023-06-22T10:00"><day>22</day><month>6</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2023</year></pub-date><volume>149</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">439007</issue-id><fpage>717</fpage><lpage>725</lpage><history><date date-type="received"><day>3</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>27</day><month>4</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>22</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-22 00:25:24.577"><day>22</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 American Medical Association. All Rights Reserved.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamaotolaryngolheadnecksurg-e231342.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamaotolaryngolheadnecksurg-e231342.pdf">jamaotolaryngolheadnecksurg-e231342.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archotol/fullarticle/10.1001/jamaoto.2023.1342"/><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-ooi230031-1"><title>Question</title><p>What is the risk of cardiovascular (CV) events in patients with head and neck squamous cell carcinoma (HNSCC) and how are CV events associated with all-cause mortality?</p></sec><sec id="ab-ooi230031-2"><title>Findings</title><p>In this cohort study of 35&#8201;897 US veterans with HNSCC, CV risk factors were highly prevalent (67% hypertension, 22% diabetes, 51% hyperlipidemia) and suboptimally controlled at time of cancer diagnosis. Ten-year cumulative incidence of stroke and myocardial infarction was 12.5% and 8.3%, respectively; incident stroke and myocardial infarction were associated with a 47% and 71% increased risk of all-cause mortality, respectively.</p></sec><sec id="ab-ooi230031-3"><title>Meaning</title><p>The results of this cohort study suggest that patients with HNSCC are at a significant risk of CV events and CV risk mitigation is essential to survivorship care.</p></sec></abstract><abstract><sec id="ab-ooi230031-4"><title>Importance</title><p>Cardiovascular (CV) disease is a substantial cause of morbidity and mortality in cancer due to shared risk factors and exposure to potentially cardiotoxic cancer therapy. However, our understanding of CV risk in patients with head and neck squamous cell carcinoma (HNSCC) is limited.</p></sec><sec id="ab-ooi230031-5"><title>Objective</title><p>To define CV risk profiles, incident stroke, myocardial infarction (MI), and mortality in patients with HNSCC.</p></sec><sec id="ab-ooi230031-6"><title>Design, Setting, and Participants</title><p>This retrospective, population-based cohort study included 35&#8201;897 US veterans with newly diagnosed HNSCC from January 1, 2000, to December 31, 2020. Data were analyzed from May 2022 to January 2023.</p></sec><sec id="ab-ooi230031-7"><title>Exposures</title><p>Demographic, cancer-specific, and treatment characteristics.</p></sec><sec id="ab-ooi230031-8"><title>Main Outcomes</title><p>Prevalence of CV risk factors, medication use, and control at HNSCC diagnosis; cumulative incidence of stroke and MI; and all-cause death.</p></sec><sec id="ab-ooi230031-9"><title>Results</title><p>Of 35&#8201;857 US veterans with HNSCC (median [IQR] age, 63 [58-69] years; 176 [0.5%] American Indian or Alaska Native, 57 [0.2%] Asian, 5321 [16.6%] Black, 207 [0.6%] Native Hawaiian or Other Pacific Islander, and 26&#8201;277 [82.0%] White individuals), there were high rates of former or current smoking (16&#8201;341 [83%]), hypertension (24&#8201;023 [67%]), diabetes (7988 [22%]), and hyperlipidemia (18&#8201;421 [51%]). Although most patients were taking risk-lowering medications, 15&#8201;941 (47%) had at least 1 uncontrolled CV risk factor. Black race was associated with increased risk of having uncontrolled CV risk factor(s) (relative risk, 1.06; 95% CI, 1.03-1.09), and patients with larynx cancer had higher rates of prevalent and uncontrolled risk factors compared with other cancer subsites. Considering death as a competing risk, the 10-year cumulative incidence of stroke and MI was 12.5% and 8.3%, respectively. In cause-specific hazards models, hypertension, diabetes, carotid artery stenosis, coronary artery disease, and presence of uncontrolled CV risk factor(s) were significantly associated with stroke and MI. In extended Cox models, incident stroke and MI were associated with a 47% (95% CI, 41%-54%) and 71% (95% CI, 63%-81%) increased risk of all-cause death, respectively.</p></sec><sec id="ab-ooi230031-10"><title>Conclusion</title><p>The results of this cohort study suggest that in HNSCC, the burden of suboptimally controlled CV risk factors and incident risk of stroke and MI are substantial. Modifiable CV risk factors are associated with risk of adverse CV events, and these events are associated with a higher risk of death. These findings identify populations at risk and potentially underscore the importance of modifiable CV risk factor control and motivate strategies to reduce CV risk in HNSCC survivorship care.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This cohort study examines cardiovascular risk profiles, incident stroke, myocardial infarction, and mortality in US veterans with head and neck squamous cell carcinoma.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>